Subsidiaries

– DIAKINISIS S.A. WAREHOUSING – TRANSPORT- PROMO
– SAMBROOK PHARMACEUTICAL S.A.
– ELGEKA (CYPRUS) LTD
– ELGEKA – FERFELIS ROMANIA S.A.
– GATEDOOR HOLDINGS LTD
– GREC-ROM BUSINESS GROUP SRL
– SC GATEDOOR HOLDINGS COM SRL
– G.S.B.G. S.A.
– ELG HOLDINGS SINGLE-MEMBER S.A.
– ELGEKA PROPERTY & DEVELOPMENT SRL

Other Investments

– C. K. PAPADIMITRIOU S.A.
– LINETTE HELLAS S.A.
– VEDIS HOLDINGS LTD

Archives (Sold – Deleted Participations)

– MEDIHELM PHARMACEUTICAL S.A.
– ELGEKA AG
– DIAKINISIS PORT (CY) LIMITED
– DIAKINISIS PORT & SIA Ε.Ε.
– P.C.D.C. S.A.
– DIAKINISIS LOGISTICS SERVICES (CY) LTD
– VIOTROS S.A.
– ΑRIVIA S.A.
– CERA VILLA DESIGN SRL
– ELGEKA FERFELIS SRL
– ELGEKA FERFELIS BULGARIA LTD

MEDIHELM PHARMACEUTICAL S.A.

REGISTERED OFFICE: MUNICIPALITY AG. ANARGYRON ATTIKI
MINISTRY OF DEVELOPMENT – GENERAL SECRETARY OF COMMERCE
(G.E.MI. NO 5786801000 – Athens Chamber of Commerce & Industry)

The company operates as a pharmaceutical wholesale store for medicines and parapharmaceutical products.

COMPANY CAPITAL: € 6.748.000

SHARΕHOLDER STRUCTURE %
ELGEKA S.A. 99,47 %
Helen E. Metsoviti 0,53 %

 

BOARD OF DIRECTORS
Alexander G. Katsiotis Chairman & Managing Director
Vasiliki K. Gatziyanni Member
Anthimos V. Misailidis Member

On 20/11/2013 ELGEKA S.A. sold its total shareholding (i.e. 99,47%) in that company.

FINANCIAL HIGHLIGHTS  2012 – 2011 ACCORDING TO I.F.R.S.

IN EURO

 2012 2011
Sales 11.403.534,35 16.993.826,24
Gross Profit / (loss) 1.792.850,73 2.586.836,14
Profit / (loss) before taxes, financing, investing activities & depreciation (473.515,74) 280.867,92
Profit / (loss) before taxes, financing & investing activities (613.488,84) 214.327,11
Profit / (loss) before taxes (912.428,03) (224.452,90)
Profit / (loss) after taxes (907.700,97) (217.137,01)
Shareholders´ Equity (576.530,43) 93.170,54

ADDRESS
4 KAZANTZAKI & AGIOU. PANTELEIMONOS STREET
AG. ANARGIRI, 13561
Tel.:  +30 210 28 48 758
Fax.: +30 210 28 14 308